Oisin Biotechnologies Company

Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.
Technology: Geroscience
Industry: Biopharma, Biotechnology, Gene therapy, Medical
Headquarters: Seattle, Washington, United States
Founded Date: 2014
Employees Number: 11-50
Funding Status: Seed
Investors Number: 6
Total Funding: 7.1M
Last Funding Date: May 27, 2021
Last Funding Type: seed round

Visit Website
Register and Claim Ownership